Literature DB >> 24576402

Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?

Matthew N Hill1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24576402      PMCID： PMC3937283          DOI： 10.1503/jpn.140028

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  31 in total

1.  Testing hypotheses about the relationship between cannabis use and psychosis.

Authors:  Louisa Degenhardt; Wayne Hall; Michael Lynskey
Journal:  Drug Alcohol Depend       Date:  2003-07-20       Impact factor: 4.492

2.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Authors:  Daniel J Foti; Roman Kotov; Lin T Guey; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

Review 3.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

Review 4.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Authors:  Daniel T Malone; Matthew N Hill; Tiziana Rubino
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  Prefrontal cortical circuits in schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Curr Top Behav Neurosci       Date:  2010

6.  If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations.

Authors:  Matt Hickman; Peter Vickerman; John Macleod; Glyn Lewis; Stan Zammit; James Kirkbride; Peter Jones
Journal:  Addiction       Date:  2009-11       Impact factor: 6.526

7.  Cannabis abuse and the course of recent-onset schizophrenic disorders.

Authors:  D H Linszen; P M Dingemans; M E Lenior
Journal:  Arch Gen Psychiatry       Date:  1994-04

8.  A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia.

Authors:  Rachel Miller; Geoffrey Ream; Joanne McCormack; Handan Gunduz-Bruce; Serge Sevy; Delbert Robinson
Journal:  Schizophr Res       Date:  2009-05-28       Impact factor: 4.939

Review 9.  Endocannabinoid functions controlling neuronal specification during brain development.

Authors:  Tibor Harkany; Erik Keimpema; Klaudia Barabás; Jan Mulder
Journal:  Mol Cell Endocrinol       Date:  2008-03-04       Impact factor: 4.102

10.  Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study.

Authors:  Rebecca Kuepper; Jenny Ceccarini; Johan Lataster; Jim van Os; Marinus van Kroonenburgh; Joop M A van Gerven; Machteld Marcelis; Koen Van Laere; Cécile Henquet
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240
View more
  3 in total

1.  Adolescence as a unique developmental period.

Authors:  Natalia Jaworska; Glenda MacQueen
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

2.  Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Authors:  Margaret Haney; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2015-08-19       Impact factor: 7.853

3.  Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility.

Authors:  David D Aguilar; Andrea Giuffrida; Daniel J Lodge
Journal:  Int J Neuropsychopharmacol       Date:  2018-04-01       Impact factor: 5.176
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.